DRUG-TREATMENT OF PRIMARY HYPERLIPOPROTEINEMIA

被引：13

作者：

KLOSE, G

MORDASINI, R

MIDDELHOFF, G

AUGUSTIN, J

GRETEN, H

机构：

来源：

KLINISCHE WOCHENSCHRIFT | 1978年 / 56卷 / 03期

关键词：

D O I：

10.1007/BF01478565

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：99 / 110

页数：12

共 152 条

[1] INHIBITION OF HEPATIC TRIGLYCERIDE FORMATION BY CLOFIBRATE [J].

ADAMS, LL ;

WEBB, WW ;

FALLON, HJ .

JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (11) :2339-&

[2] MANAGEMENT OF HYPERLIPIDEMIA - WHETHER, RATHER THAN HOW [J].

AHRENS, EH .

ANNALS OF INTERNAL MEDICINE, 1976, 85 (01) :87-93

[3]

ALAUPOVIC RP, 1963, J ATHEROSCLER RES, V3, P482

[4] INFLUENCE OF NICOTINIC ACID ON SERUM CHOLESTEROL IN MAN [J].

ALTSCHUL, R ;

HOFFER, A ;

STEPHEN, JD .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1955, 54 (02) :558-559

[5]

Anitschkow N, 1913, BEITR PATHOL ANAT AL, V56, P379

[6]

AUGUSTIN J, 1976, HDB INNEREN MEDIZIN, V7, P219

[7] BINDING TO PLASMA LIPOPROTEINS OF CHLOROPHENOXYISOBUTYRIC, TIBRIC AND NICOTINIC ACIDS AND THEIR ESTERS - ITS SIGNIFICANCE FOR MECHANISM OF LIPID LOWERING BY CLOFIBRATE AND RELATED DRUGS [J].

BEAUMONT, JL ;

DACHET, C .

ATHEROSCLEROSIS, 1976, 25 (2-3) :255-266

[8]

BENCZE WL, 1969, PROGR DRUG RES, P13

[9]

BERGEN SS, 1959, P SOC EXP BIOL MED, V102, P676, DOI 10.3181/00379727-102-25358

[10]

BERGEN SS, 1963, ANN INTERN MED, V38, P355

← 1 2 3 4 5 6 7 8 9 10 →